Novabridge Biosciences ADR
NBP3.980USD
+0.010+0.25%
收盘 01/27, 16:00（美东）报价延迟15分钟
458.86M总市值
亏损市盈率 TTM
关于 公司
Novabridge Biosciences ADR简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
Novabridge Biosciences ADR公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Wei Fu
Mr. Wei Fu
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Chun Kwok (Alan) Au
Mr. Chun Kwok (Alan) Au
Independent Director
Independent Director
--
--
Mr. Chia-Hung (Conor) Yang
Mr. Chia-Hung (Conor) Yang
Independent Director
Independent Director
--
--
Dr. Phillip Dennis, M.D., Ph.D.
Dr. Phillip Dennis, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Xi-Yong (Sean) Fu, Ph.D.
Dr. Xi-Yong (Sean) Fu, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Robert Lenz, M.D., Ph.D.
Dr. Robert Lenz, M.D., Ph.D.
Independent Director
Independent Director
--
--
,
,
Independent Director
Independent Director
--
--
,
,
Chief Business Development Officer, Director
Chief Business Development Officer, Director
--
--
Mr. Kyler Lei
Mr. Kyler Lei
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Claire Xu
Mr. Claire Xu
Senior Vice President - Clinical Development
Senior Vice President - Clinical Development
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Wei Fu
Mr. Wei Fu
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Chun Kwok (Alan) Au
Mr. Chun Kwok (Alan) Au
Independent Director
Independent Director
--
--
Mr. Chia-Hung (Conor) Yang
Mr. Chia-Hung (Conor) Yang
Independent Director
Independent Director
--
--
Dr. Phillip Dennis, M.D., Ph.D.
Dr. Phillip Dennis, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Xi-Yong (Sean) Fu, Ph.D.
Dr. Xi-Yong (Sean) Fu, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Robert Lenz, M.D., Ph.D.
Dr. Robert Lenz, M.D., Ph.D.
Independent Director
Independent Director
--
--
收入明细
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
China (Mainland)
0.00
0.00%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 1月11日 周日
更新时间: 1月11日 周日
持股股东
股东类型
持股股东
持股股东
占比
Everest Medicines Ltd
13.74%
CBC Group
10.37%
T Investment Ltd
7.09%
Janus Henderson Investors
6.93%
HHLR Advisors, Ltd.
5.19%
其他
56.68%
持股股东
持股股东
占比
Everest Medicines Ltd
13.74%
CBC Group
10.37%
T Investment Ltd
7.09%
Janus Henderson Investors
6.93%
HHLR Advisors, Ltd.
5.19%
其他
56.68%
股东类型
持股股东
占比
Corporation
20.83%
Investment Advisor/Hedge Fund
14.77%
Private Equity
10.37%
Hedge Fund
7.26%
Investment Advisor
3.84%
Research Firm
1.69%
Individual Investor
0.56%
Venture Capital
0.26%
Sovereign Wealth Fund
0.06%
其他
40.36%
机构持股
更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
71
44.19M
22.87%
--
2025Q4
105
44.78M
38.84%
+10.48M
2025Q3
118
43.87M
38.07%
+959.09K
2025Q2
118
26.13M
31.79%
-13.78M
2025Q1
122
24.15M
29.39%
-18.93M
2024Q4
134
22.41M
27.40%
-20.19M
2024Q3
146
29.96M
36.94%
-20.28M
2024Q2
191
30.91M
38.11%
-23.68M
2024Q1
262
28.58M
35.04%
-19.41M
2023Q4
293
28.92M
35.46%
-21.29M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Everest Medicines Ltd
15.85M
13.74%
+15.85M
--
Aug 05, 2025
CBC Group
11.95M
10.37%
-2.64M
-18.11%
Aug 05, 2025
T Investment Ltd
8.17M
7.09%
--
--
Mar 19, 2025
Janus Henderson Investors
7.99M
6.93%
+7.99M
--
Sep 30, 2025
HHLR Advisors, Ltd.
5.98M
5.19%
--
--
Sep 30, 2025
Adage Capital Management, L.P.
3.34M
2.9%
+3.34M
--
Sep 30, 2025
Ariose Capital Management Limited
1.70M
1.48%
+1.61M
+1667.03%
Sep 30, 2025
Candriam Luxembourg S.A.
1.61M
1.4%
+2.26K
+0.14%
Nov 30, 2025
Exome Asset Management LLC
1.44M
1.25%
+1.44M
--
Sep 30, 2025
Morgan Stanley & Co. LLC
1.36M
1.18%
+1.30M
+2235.39%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月9日 周二
更新时间: 12月9日 周二
机构名称
占比
ALPS Barron's 400 ETF
0.23%
SPDR S&P Emerging Markets Small Cap ETF
0.03%
SPDR S&P China ETF
0.01%
SPDR Portfolio Emerging Markets ETF
0.01%
ActivePassive International Equity ETF
0%
Avantis Emerging Markets Small Cap Equity ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Invesco Golden Dragon China ETF
0%
SPDR S&P Emerging Asia Pacific ETF
0%
ALPS Barron's 400 ETF
占比0.23%
SPDR S&P Emerging Markets Small Cap ETF
占比0.03%
SPDR S&P China ETF
占比0.01%
SPDR Portfolio Emerging Markets ETF
占比0.01%
ActivePassive International Equity ETF
占比0%
Avantis Emerging Markets Small Cap Equity ETF
占比0%
Invesco NASDAQ Future Gen 200 ETF
占比0%
Invesco Golden Dragon China ETF
占比0%
SPDR S&P Emerging Asia Pacific ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
